Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy
Arturo Casadevall, Michael J. Joyner, Liise-anne Pirofski, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 5, pp. 381-395
Closed Access | Times Cited: 25

Showing 25 citing articles:

COVID-19 therapeutics
Daniele Focosi, Massimo Franchini, Fabrizio Maggi, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 8
Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19
Juan G. Ripoll, Sidna M. Tulledge‐Scheitel, Anthony A. Stephenson, et al.
mBio (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 5
Estimates of Actual and Potential Lives Saved in the United States from the use of COVID-19 Convalescent Plasma
Quigly Dragotakes, Patrick W. Johnson, Matthew R. Buras, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Estimates of actual and potential lives saved in the United States from the use of COVID-19 convalescent plasma
Quigly Dragotakes, Patrick W. Johnson, Matthew R. Buras, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 41
Open Access | Times Cited: 4
Safety of COVID‐19 convalescent plasma: A definitive systematic review and meta‐analysis of randomized controlled trials
Massimo Franchini, Mario Cruciani, Arturo Casadevall, et al.
Transfusion (2023) Vol. 64, Iss. 2, pp. 388-399
Closed Access | Times Cited: 11
Double-blinded, randomised, placebo-controlled trial of convalescent plasma for COVID-19: analyses by neutralising antibodies homologous to recipients’ variants
Tuba Khawaja, Mikael Kajova, Iris Levonen, et al.
Infectious Diseases (2024) Vol. 56, Iss. 6, pp. 423-433
Open Access | Times Cited: 3
Hyperimmune Plasma and Immunoglobulins against COVID-19: A Narrative Review
Massimo Franchini, Daniele Focosi
Life (2024) Vol. 14, Iss. 2, pp. 214-214
Open Access | Times Cited: 2
The value of observational registry studies for the next infectious disease emergency
Jonathon W. Senefeld, Peter Marks, Arturo Casadevall, et al.
mBio (2023) Vol. 14, Iss. 6
Open Access | Times Cited: 5
Convalescent plasma: An unexpected new therapeutic option for critically ill COVID-19 patients coming from the past
Massimo Franchini, Arturo Casadevall, Mario Cruciani, et al.
Journal of Clinical Anesthesia (2024) Vol. 94, pp. 111411-111411
Closed Access | Times Cited: 1
Harnessing immunity: Immunomodulatory therapies in COVID-19
Tsvetelina Velikova, Hristo Valkov, A Aleksandrova, et al.
World Journal of Virology (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 1
The Importance of Geographic Proximity of Convalescent Plasma Donors
Katie L. Kunze, Patrick W. Johnson
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 1
SARS-CoV-2 ferritin nanoparticle vaccines produce hyperimmune equine sera with broad sarbecovirus activity
Elizabeth J. Martinez, William C. Chang, Wei‐Hung Chen, et al.
iScience (2024) Vol. 27, Iss. 10, pp. 110624-110624
Open Access | Times Cited: 1
Evidence for the Efficacy of COVID-19 Convalescent Plasma
Stephen A. Klassen, Jonathon W. Senefeld
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 1
A Brief History of Polyclonal Antibody Therapies Against Bacterial and Viral Diseases Before COVID-19
Nigel Paneth, M. WALSH, Breanna Kornatowski, et al.
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 1
The Importance of Antibody Titer Determination to the Effective Use of Convalescent Plasma
Peter Marks
Current topics in microbiology and immunology (2024)
Closed Access | Times Cited: 1
Serum anti‐Spike immunoglobulin G levels in random blood donors in Italy: High‐titre convalescent plasma is easier than ever to procure
Daniele Focosi, Silvia Meschi, Sabrina Coen, et al.
Vox Sanguinis (2023) Vol. 118, Iss. 9, pp. 794-797
Closed Access | Times Cited: 4
Hyperimmune Plasma and Immunoglobulins Against COVID-19: A Narrative Review
Massimo Franchini, Daniele Focosi
(2023)
Open Access | Times Cited: 3
COVID-19 convalescent plasma retains value for immunocompromised patients
Daniele Focosi, Massimo Franchini
Leukemia (2023) Vol. 37, Iss. 8, pp. 1762-1763
Closed Access | Times Cited: 2
Convalescent Plasma for Covid-19–Induced ARDS
Jonathon W. Senefeld, Jeffrey P. Henderson, Michael J. Joyner
New England Journal of Medicine (2024) Vol. 390, Iss. 4, pp. 384-386
Open Access
Convalescent Plasma for Critically-ill Covid-19 Patients
Adel A. Aljatham, Waleed T. Hashim, Mohamad A. Almashiakhi, et al.
Research Square (Research Square) (2024)
Open Access
The Logic and History of Passive Immunity and Antibody Therapies
Arturo Casadevall, Nigel Paneth
Current topics in microbiology and immunology (2024)
Closed Access
CONVALESCENT PLASMA THERAPY FOR COVID-19 – DONOR SELECTION STRATEGIES AND ESTABLISHMENT OF A PLASMA BANK
Mikael Kajova, Tamim Khawaja, Iris Levonen, et al.
New Microbes and New Infections (2024) Vol. 62, pp. 101525-101525
Open Access
The Role of Convalescent Plasma in COVID-19: A Conclusive Post-Pandemic Review
Massimo Franchini, Daniele Focosi
Life (2023) Vol. 13, Iss. 12, pp. 2322-2322
Open Access | Times Cited: 1
Chinese expert consensus on the management of patients with hematologic malignancies infected with SARS-CoV-2
Jun Wang, Liang Shao, Jing Liang, et al.
Journal of Cancer Research and Therapeutics (2023) Vol. 19, Iss. 6, pp. 1495-1500
Open Access | Times Cited: 1
Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19
Juan G. Ripoll, Sidna M. Tulledge‐Scheitel, Anthony A. Stephenson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top